IL-17i clinical trials

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

This study looks at how well new and existing treatments for Psoriatic Arthritis, called guselkumab and IL-17 inhibitors, work in people's everyday lives. It aims to understand how long people stay on these medicines and their real-world impact.